CDK6 and esophageal squamous cell carcinoma: Collectively, our data indicated that low expression of CDK6 and/or high expression of Cyclin D1 were correlated with the high sensitivity of SHR6390 in ESCC, which would be helpful to select patients benefit from SHR6390.